Nigeria’s battle against HIV is faltering as critical diagnostic tests, including resistance testing, CD4 counts, hemoglobin ...
Known medically as metabolic dysfunction-associated steatotic liver disease, it is not linked to heavy drinking-the more ...
Being on the keto diet for a long time may does more harm than good to metabolic health. A yearlong study in mice showed that although the diet initially reduced their weight, over time it led to ...
Mayo Clinic scientists uncovered how excessive drinking triggers fatty liver disease by disrupting the enzyme VCP, which normally prevents harmful protein buildup on fat droplets in the liver. Alcohol ...
Dealbreaker on MSN
Roche’s Metabolic Drug Strategy Extends to the Liver Disease MASH With $2.4B 89bio Acquisition
Roche is buying 89bio to get pegozafermin, a drug currently in two Phase 3 studies for the fatty liver disease MASH.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback